Lung transplantation for rare pulmonary diseases

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 22, Issue SUPPL. 1, 2005, Pages

  Saleem, Imran ^a   Moss, Joel ^b   Egan, Jim J ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Lung transplant; Lymphangioleiomyomatosis; Pulmonary Langerhans Cell Histiocytosis X; Sarcoid

Indexed keywords

CONFERENCE PAPER; DISEASE SEVERITY; HISTIOCYTOSIS X; HUMAN; IDIOPATHIC DISEASE; LANGERHANS CELL; LUNG DISEASE; LUNG FIBROSIS; LUNG SARCOIDOSIS; LUNG TRANSPLANTATION; LYMPHANGIOLEIOMYOMATOSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RARE DISEASE; RECURRENT DISEASE; TREATMENT INDICATION;

FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; LUNG TRANSPLANTATION; LYMPHANGIOLEIOMYOMATOSIS; MALE; PROGNOSIS; RISK ASSESSMENT; SARCOIDOSIS, PULMONARY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 31544447496     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI: The Registry of the International Society for Heart and Lung Transplantation: Twenty-first official adult lung and heart-iung transplant report - 2004. J Heart Lung Transplant 2004; 23: 804-15.
2. Fartoukh M, Humbert M, Capron F, Maitre S: Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000; 161: 216-23.
3. Delobbe A, Durieu J, Duhamel A, Wallaert B: Determinants of survival in pulmonary Langerhans cell granulomatosis (histiocytosis X). Eur Respir J 1996; 9: 2002-6.
4. Etienne B, Bertocchi M, Gamondes JP, et al: Relapsing Pulmonary Langerhans Cell Histiocytosis after Lung Transplantation. Am J Respir Crit Care Med 1998; 157: 288-91.
5. Collins J, Hartman MJ, Warne TF, et al: Frequency and CT findings of recurrent disease after Lung transplantation. Radiology 2001; 219: 503-9.
6. Gabbay E, Dark JH, Ashcroft T, et al: Recurrence of Langerhans cell granulomatosis following lung transplantation. Thorax 1998; 53: 326-7.
7. Chu SC, Horiba K, Usuki J, et al: Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest 1999; 115: 1041-52.
8. Matsui K, Beasley MB, Nelson WK, et al: Prognostic significance of pulmonary lymphangioleiomyomatosis histologic score. Am J Surg Pathol 2001; 25: 479-84.
9. Taveira-Da Silva AM, Hedin C, Stylianou MP, et al: Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis. Am J Respir Crit Care Med 2001; 164: 1072-6.
10. Taveira-Da Silva AM, Stylianou MP, Hedin CJ, et al: Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis. Am J Respir Crit Care Med 2003; 168: 1427-31.
11. Avila NA, Chen CC, Chu SC, et al: Pulmonary lymphangioleiomyomatosis: correlation of ventilation-perfusion scintigraphy, chest radiography, and CT with pulmonary function tests. Radiology 2000; 214: 441-6.
12. Boehler A, Speich R, Russi EW, Weder W: Lung transplantation for lymphangioleiomyomatosis. N Engl J Med 1996; 335: 1275-80.
13. Pechet T, Meyers BF, Guthrie TJ, et al: Lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transplant 2004; 23: 301-8.
14. Karbowniczek M, Astrinidis A, Balsara BR, et al: Recurrent Lymphangiomyomatosis after Transplantation. Genetic Analyses Reveal a Metastatic Mechanism. Am J Respir Crit Care Med 2003; 167: 976-82.
15. Crooks DM, Pacheco-Rodriguez G, Decastro RM, et al: Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis. Proc Natl Acad Sci USA 2004; 101: 17462-7.
16. Arcasoy SM, Christie JD, Pochettino A, et al: Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest 2001; 120: 873-80.
17. Shorr AF, Davies DB, Nathan SD: Outcomes for patients with sarcoidosis awaiting lung transplantation. Chest 2002; 122: 233-8.
18. Preston IR, Klinger JR, Landzberg MJ, Houtchens J, Nelson D, Hill NS: Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension. Chest 2001; 120: 866-72.
19. Nunley DR, Hattler B, Keenan RJ, et al: Lung transplantation for end-stage pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 93-100.
20. Walker S, Mikhail G, Banner N, et al: Medium term results of lung transplantation for end stage pulmonary sarcoidosis. Thorax 1998; 53: 281-4.